phenazopyridine has been researched along with bethanechol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrueto, F; Beuerle, JR | 1 |
1 other study(ies) available for phenazopyridine and bethanechol
Article | Year |
---|---|
Neurogenic bladder and chronic urinary retention associated with MDMA abuse.
Topics: Adult; Amphetamine-Related Disorders; Anti-Infective Agents, Urinary; Bethanechol; Central Nervous System Stimulants; Chronic Disease; Cystoscopy; Humans; Male; Muscarinic Agonists; N-Methyl-3,4-methylenedioxyamphetamine; Phenazopyridine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Retention | 2008 |